K. Moore

发表

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Michael Lock, Stewart Gaede, Suresh Senan, 2019, The Lancet.

The potential clinical benefit of respiratory gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC).

R. Muirhead, K. Moore, C. Featherstone, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial

N. O'Rourke, A. Price, B. Laird, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Using Radiotherapy to Treat Pain in Mesothelioma

N. O'Rourke, A. Price, B. Laird, 2015 .

Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

B. Yaremko, M. Lock, S. Senan, 2019, International journal of radiation oncology, biology, physics.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020, medRxiv.

F-18 FDG PET-CT Influences Target Delineation When Combined With Standard CT-Based Radiotherapy Planning in the Palliative Setting in Malignant Pleural Mesothelioma; an Exploratory Study

F. W. Poon, N. O'Rourke, B. Laird, 2015 .

Stereotactic ablative body radiotherapy for non-small-cell lung cancer: setup reproducibility with novel arms-down immobilization.

J. Hicks, S. Harrow, K. Moore, 2016, The British journal of radiology.

Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2018, International Journal of Radiation Oncology*Biology*Physics.

Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours.

D. Soutar, P. Canney, H. Yosef, 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma

N. O'Rourke, B. Laird, K. Franks, 2017, Clinical and translational radiation oncology.

Use of Maximum Intensity Projections (MIPs) for Target Outlining in 4DCT Radiotherapy Planning

R. Muirhead, K. Moore, S. Muscat, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic ablative body radiotherapy for non-small-cell lung cancer: setup reproducibility with novel arms-down immobilization

J. Hicks, S. Harrow, K. Moore, 2016 .

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial

B. Yaremko, M. Lock, S. Senan, 2020 .

Diversity in radiation therapist/therapeutic radiographer (RTT) advanced practice (AP) roles delivering on the four domains

K. Moore, A. Duffton, A. Williamson, 2021, Technical innovations & patient support in radiation oncology.